Kenji Kitano

721 total citations
16 papers, 609 citations indexed

About

Kenji Kitano is a scholar working on Infectious Diseases, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Kenji Kitano has authored 16 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Organic Chemistry and 6 papers in Molecular Biology. Recurrent topics in Kenji Kitano's work include HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (5 papers) and Biochemical and Molecular Research (5 papers). Kenji Kitano is often cited by papers focused on HIV/AIDS drug development and treatment (10 papers), HIV Research and Treatment (5 papers) and Biochemical and Molecular Research (5 papers). Kenji Kitano collaborates with scholars based in Japan and United States. Kenji Kitano's co-authors include Hiroshi Ohrui, Eiichi Kodama, Satoru Kohgo, Shinji Sakata, Shinji Miura, Hiroaki Mitsuya, Masao Matsuoka, Yuichi Yoshimura, Shirô Shigeta and Takuma Sasaki and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and The Journal of Organic Chemistry.

In The Last Decade

Kenji Kitano

16 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenji Kitano Japan	11	425	279	264	232	122	16	609
Mei‐Zhen Luo United States	9	243 0.6×	276 1.0×	163 0.6×	94 0.4×	130 1.1×	21	454
R Mathis United States	4	456 1.1×	266 1.0×	166 0.6×	245 1.1×	168 1.4×	4	596
Shizuko Aoki United States	8	321 0.8×	193 0.7×	105 0.4×	170 0.7×	172 1.4×	9	511
Satoru Kohgo Japan	15	620 1.5×	279 1.0×	161 0.6×	434 1.9×	245 2.0×	35	812
Takashi Kawasuji Japan	14	630 1.5×	386 1.4×	313 1.2×	523 2.3×	115 0.9×	22	961
Vandna Munshi United States	13	357 0.8×	208 0.7×	227 0.9×	278 1.2×	105 0.9×	14	592
Anastasia L. Khandazhinskaya Russia	15	344 0.8×	347 1.2×	288 1.1×	69 0.3×	228 1.9×	82	715
Joseph H. Chan United States	13	293 0.7×	195 0.7×	411 1.6×	228 1.0×	222 1.8×	19	833
Anne-Marie Aubertin France	10	193 0.5×	200 0.7×	109 0.4×	91 0.4×	65 0.5×	12	339
Tatiana V. Ilina United States	10	275 0.6×	258 0.9×	132 0.5×	204 0.9×	49 0.4×	24	461

Countries citing papers authored by Kenji Kitano

Since Specialization

Citations

This map shows the geographic impact of Kenji Kitano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Kitano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Kitano more than expected).

Fields of papers citing papers by Kenji Kitano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Kitano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Kitano. The network helps show where Kenji Kitano may publish in the future.

Co-authorship network of co-authors of Kenji Kitano

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Kitano. A scholar is included among the top collaborators of Kenji Kitano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Kitano. Kenji Kitano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kawamoto, Atsushi, Eiichi Kodama, Stefan G. Sarafianos, et al.. (2008). 2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants. The International Journal of Biochemistry & Cell Biology. 40(11). 2410–2420. 99 indexed citations

Kohgo, Satoru, Kohei Yamada, Kenji Kitano, et al.. (2004). Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 23(4). 671–690. 39 indexed citations

Hayakawa, Hiroyuki, Satoru Kohgo, Kenji Kitano, et al.. (2004). Potential of 4′-C-Substituted Nucleosides for the Treatment of HIV-1. Antiviral chemistry & chemotherapy. 15(4). 169–187. 41 indexed citations

Kitano, Kenji, Satoru Kohgo, Kohei Yamada, et al.. (2004). Attempt to Reduce Cytotoxicity by Synthesizing the L-Enantiomer of 4′-C-Ethynyl-2′-Deoxypurine Nucleosides as Antiviral Agents against HIV and HBV. Antiviral chemistry & chemotherapy. 15(3). 161–167. 3 indexed citations

Kohgo, Satoru, Kohei Yamada, Kenji Kitano, et al.. (2003). Synthesis of 4′-C-Ethynyl and 4′-C-Cyano Purine Nucleosides from Natural Nucleosides and Their Anti-HIV Activity. Nucleosides Nucleotides & Nucleic Acids. 22(5-8). 887–889. 3 indexed citations

Kodama, Eiichi, Satoru Kohgo, Kenji Kitano, et al.. (2001). 4′-Ethynyl Nucleoside Analogs: Potent Inhibitors of Multidrug-Resistant Human Immunodeficiency Virus Variants In Vitro. Antimicrobial Agents and Chemotherapy. 45(5). 1539–1546. 113 indexed citations

Ohrui, Hiroshi, Satoru Kohgo, Kenji Kitano, et al.. (2000). Syntheses of 4‘-C-Ethynyl-β-d-arabino- and 4‘-C-Ethynyl-2‘-deoxy-β-d-ribo-pentofuranosylpyrimidines and -purines and Evaluation of Their Anti-HIV Activity. Journal of Medicinal Chemistry. 43(23). 4516–4525. 70 indexed citations

Yoshimura, Yuichi, Kenji Kitano, Kohei Yamada, et al.. (1999). Synthetic Studies on 2′-Substituted-4′-thiocytidine Derivatives as Antineoplastic Agents. Nucleosides and Nucleotides. 18(4-5). 815–820. 4 indexed citations

Kitano, Kenji, Haruhiko Machida, Shinji Miura, & Hiroshi Ohrui. (1999). Synthesis of novel 4′-C-methyl-pyrimidine nucleosides and their biological activities. Bioorganic & Medicinal Chemistry Letters. 9(6). 827–830. 11 indexed citations

10.

Machida, Haruhiko, Noriyuki Ashida, Shinji Miura, et al.. (1998). Anti-herpesvirus activity profile of 4′-thioarabinofuranosyl purine and uracil nucleosides and activity of 1-β-d-2′-fluoro-4′-thioarabinofuranosyl guanine and 2,6-diaminopurine against clinical isolates of human cytomegalovirus. Antiviral Research. 39(2). 129–137. 11 indexed citations

11.

Yoshimura, Yuichi, Kenji Kitano, Hiroshi Satoh, et al.. (1997). Synthesis and Biological Activities of 2′-Modified 4′-Thionucleosides. Nucleosides and Nucleotides. 16(7-9). 1103–1106. 6 indexed citations

12.

Yoshimura, Yuichi, Kenji Kitano, Kohei Yamada, et al.. (1997). A Novel Synthesis of 2‘-Modified 2‘-Deoxy-4‘-thiocytidines from d-Glucose¹. The Journal of Organic Chemistry. 62(10). 3140–3152. 87 indexed citations

13.

Kitano, Kenji, Shinji Miura, Hiroshi Ohrui, & Hiroshi Meguro. (1997). Synthesis of 4′-C-fluoromethylnucleosides as potential antineoplastic agents. Tetrahedron. 53(39). 13315–13322. 32 indexed citations

14.

Yoshimura, Yuichi, Kenji Kitano, Hiroshi Satoh, et al.. (1996). A Novel Synthesis of New Antineoplastic 2‘-Deoxy-2‘-substituted-4‘-thiocytidines. The Journal of Organic Chemistry. 61(3). 822–823. 73 indexed citations

15.

Kitano, Kenji, Nobuya Katagiri, & Chikara Kaneko. (1994). Dimethyl 2-{3,3-Bis(methoxycarbonyl)bicyclo[2.2.1]hept-5-en-2-yl}malonate. Synthesis and Base-Catalyzed C–C Bond Cleavage Reaction. Chemistry Letters. 23(7). 1285–1288. 2 indexed citations

16.

Katagiri, Nobuya, et al.. (1994). Explanation for Stereoselectivity of the cis-Dihydroxylation of cis-3,5-disubstituted Cyclopentenes.. Chemical and Pharmaceutical Bulletin. 42(12). 2653–2655. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact